Bleomycin-induced fibrosis in MC1 signalling-deficient C57BL/6J-Mc1re/e mice further supports a modulating role for melanocortins in collagen synthesis of the skin

Experimental Dermatology

Volumn 23, Issue 6, 2014, Pages 431-433

  Böhm, Markus ^a   Stegemann, Agatha ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bleomycin; Collagen; Fibroblasts; Fibrosis; Neuropeptides

Indexed keywords

BLEOMYCIN; COLLAGEN TYPE 1; CONNECTIVE TISSUE GROWTH FACTOR; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RNA; CCL2 PROTEIN, MOUSE; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SKIN FIBROSIS; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DEFICIENCY; DISEASE MODEL; FIBROSIS; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTANT MOUSE STRAIN; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; SYSTEMIC SCLEROSIS;

ANIMALS; BLEOMYCIN; CHEMOKINE CCL2; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; FIBROSIS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; MELANOCORTINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; RECEPTOR, MELANOCORTIN, TYPE 1; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; SKIN;

EID: 84901478971     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12409     Document Type: Article

References (30)

1. Slominski A, Tobin D J, Shibahara S et al. Physiol Rev 2004: 84: 1155-1228.
2. Slominski A, Wortsman J, Luger T et al. Physiol Rev 2000: 80: 979-1020.
3. Böhm M, Luger T A, Tobin D J et al. J Invest Dermatol 2006: 126: 1966-1975.
4. Böhm M, Raghunath M, Sunderkötter C et al. J Biol Chem 2004: 279: 6959-6966.
5. Böhm M, Luger T A. Exp Dermatol 2004: 13(Suppl 4): 16-21.
6. Böhm M, Eickelmann M, Li Z et al. Endocrinology 2005: 146: 4635-4646.
7. Kokot A, Sindrilaru A, Schiller M et al. Arthritis Rheum 2009: 60: 592-603.
8. Wang C H, Lee T H, Lu C N et al. Gene Ther 2006: 13: 1000-1009.
9. Xu P B, Mao Y F, Meng H B et al. Shock 2011: 35: 308-314.
10. Robbins L S, Nadeau J H, Johnson K R et al. Cell 1993: 72: 827-834.
11. Yamamoto T, Kuroda M, Nishioka K. Arch Dermatol Res 2000: 292: 535-541.
12. Stegemann A, Sindrilaru A, Eckes B et al. Arthritis Rheum 2013: 65: 792-804.
13. Yamamoto T, Nishioka K. Exp Dermatol 2005: 14: 81-95.
14. Yamamoto T, Takagawa S, Katayama I et al. J Invest Dermatol 1999: 112: 456-462.
15. Brzoska T, Luger T A, Maaser C et al. Endocr Rev 2008: 29: 581-602.
16. Maaser C, Kannengiesser K, Specht C et al. Gut 2006: 55: 1415-1422.
17. Wolnicka-Glubisz A, De Fabo E, Noonan F. Exp Dermatol 2013: 22: 226-228.
18. Giri S N, Chen Z L, Younker W R et al. Toxicol Appl Pharmacol 1983: 71: 132-141.
19. Inghilleri S, Morbini P, Oggionni T et al. Histochem Cell Biol 2006: 125: 661-669.
20. Hagiwara S I, Ishii Y, Kitamura S. Am J Respir Crit Care Med 2000: 162: 225-231.
21. Serrano-Mollar A, Closa D, Prats N et al. Br J Pharmacol 2003: 138: 1037-1048.
22. Yamamoto T, Takagawa S, Katayama I et al. J Invest Dermatol 1999: 13: 843-847.
23. Bowler R P, Nicks M, Warnick K et al. Am J Physiol Lung Cell Mol Physiol 2002: 282: L719-L726.
24. Mitra D, Luo X, Morgan A et al. Nature 2012: 491: 449-453.
25. Loser K, Brzoska T, Oji V et al. PLoS ONE 2010: 5: e8958.
26. Ishikawa H, Takeda K, Okamoto A et al. J Invest Dermatol 2009: 129: 1688-1695.
27. Yoshizaki A, Yanaba K, Iwata Y et al. J Immunol 2010: 185: 2502-2515.
28. Okamoto Y, Hasegawa M, Matsushita T et al. Arthritis Rheum 2012: 64: 3726-3735.
29. Ohgo S, Hasegawa S, Hasebe Y et al. Exp Dermatol 2013: 22: 769-771.
30. Muffley L A, Zhu K Q, Engrav L H et al. J Histochem Cytochem 2011: 59: 278-288.